Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
India
· Delayed Price · Currency is INR 1,200.15
+49.05 (4.26%)
Sep 6, 2024, 3:30 PM IST
Suven Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Operating Revenue | 9,345 | 10,514 | 13,403 | 13,202 | 10,097 | 8,338 | Upgrade
|
| Other Revenue | - | - | - | - | -0 | - | Upgrade
|
| Revenue | 9,345 | 10,514 | 13,403 | 13,202 | 10,097 | 8,338 | Upgrade
|
| Revenue Growth (YoY) | -30.73% | -21.56% | 1.52% | 30.75% | 21.10% | -8.05% | Upgrade
|
| Cost of Revenue | 4,074 | 4,503 | 5,882 | 5,741 | 4,372 | 3,342 | Upgrade
|
| Gross Profit | 5,271 | 6,010 | 7,521 | 7,461 | 5,725 | 4,996 | Upgrade
|
| Selling, General & Admin | 1,552 | 1,403 | 1,218 | 1,024 | 784.18 | 695.06 | Upgrade
|
| Research & Development | - | - | - | 103.55 | 110.58 | 141.32 | Upgrade
|
| Other Operating Expenses | 506.59 | 516.59 | 561.82 | 526.62 | 415.35 | 340.68 | Upgrade
|
| Operating Expenses | 2,612 | 2,465 | 2,259 | 2,045 | 1,626 | 1,412 | Upgrade
|
| Operating Income | 2,659 | 3,545 | 5,262 | 5,416 | 4,099 | 3,584 | Upgrade
|
| Interest Expense | -71.91 | -74.51 | -128.11 | -62.31 | -91.44 | -199.15 | Upgrade
|
| Interest & Investment Income | 20.15 | 20.15 | 58.32 | 0.69 | 2.68 | 3.61 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 411.12 | 537.36 | 482.13 | Upgrade
|
| Currency Exchange Gain (Loss) | 81.23 | 81.23 | 214.38 | 164.21 | 95.59 | 110.37 | Upgrade
|
| Other Non Operating Income (Expenses) | 140.73 | 65.83 | 32.9 | 0.02 | 0 | 1.46 | Upgrade
|
| EBT Excluding Unusual Items | 2,829 | 3,638 | 5,439 | 5,930 | 4,643 | 3,982 | Upgrade
|
| Merger & Restructuring Charges | -32.24 | -32.24 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 449.11 | 449.11 | 156.87 | 636.14 | 33.28 | 62.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.68 | -0.68 | -0.07 | 106.03 | 0.34 | 0.58 | Upgrade
|
| Other Unusual Items | 2.73 | 2.73 | 1.17 | 3.73 | - | - | Upgrade
|
| Pretax Income | 3,248 | 4,057 | 5,597 | 6,676 | 4,677 | 4,045 | Upgrade
|
| Income Tax Expense | 843.61 | 1,054 | 1,484 | 2,138 | 1,053 | 875.1 | Upgrade
|
| Net Income | 2,405 | 3,003 | 4,113 | 4,538 | 3,623 | 3,170 | Upgrade
|
| Net Income to Common | 2,405 | 3,003 | 4,113 | 4,538 | 3,623 | 3,170 | Upgrade
|
| Net Income Growth | -43.34% | -26.99% | -9.37% | 25.24% | 14.30% | 20.87% | Upgrade
|
| Shares Outstanding (Basic) | 255 | 255 | 255 | 255 | 255 | 255 | Upgrade
|
| Shares Outstanding (Diluted) | 255 | 255 | 255 | 255 | 255 | 255 | Upgrade
|
| Shares Change (YoY) | 0.05% | - | - | - | -0.00% | 0.00% | Upgrade
|
| EPS (Basic) | 9.45 | 11.80 | 16.16 | 17.83 | 14.23 | 12.45 | Upgrade
|
| EPS (Diluted) | 9.45 | 11.80 | 16.16 | 17.83 | 14.23 | 12.45 | Upgrade
|
| EPS Growth | -43.36% | -26.99% | -9.37% | 25.28% | 14.30% | 20.85% | Upgrade
|
| Free Cash Flow | - | 3,067 | 1,713 | 2,548 | 2,717 | 3,039 | Upgrade
|
| Free Cash Flow Per Share | - | 12.05 | 6.73 | 10.01 | 10.67 | 11.94 | Upgrade
|
| Dividend Per Share | - | - | - | 2.000 | 2.000 | 1.250 | Upgrade
|
| Dividend Growth | - | - | - | 0% | 60.00% | -30.56% | Upgrade
|
| Gross Margin | 56.41% | 57.17% | 56.11% | 56.51% | 56.70% | 59.92% | Upgrade
|
| Operating Margin | 28.45% | 33.72% | 39.26% | 41.03% | 40.59% | 42.98% | Upgrade
|
| Profit Margin | 25.73% | 28.56% | 30.69% | 34.37% | 35.89% | 38.02% | Upgrade
|
| Free Cash Flow Margin | - | 29.17% | 12.78% | 19.30% | 26.91% | 36.44% | Upgrade
|
| EBITDA | 3,190 | 4,063 | 5,726 | 5,795 | 4,407 | 3,817 | Upgrade
|
| EBITDA Margin | 34.14% | 38.65% | 42.72% | 43.89% | 43.65% | 45.78% | Upgrade
|
| D&A For EBITDA | 531.42 | 518.06 | 464.6 | 378.64 | 308.36 | 233.32 | Upgrade
|
| EBIT | 2,659 | 3,545 | 5,262 | 5,416 | 4,099 | 3,584 | Upgrade
|
| EBIT Margin | 28.45% | 33.72% | 39.26% | 41.03% | 40.59% | 42.98% | Upgrade
|
| Effective Tax Rate | 25.97% | 25.98% | 26.52% | 32.02% | 22.52% | 21.63% | Upgrade
|
| Revenue as Reported | 10,039 | 11,133 | 13,867 | 14,126 | 10,240 | 8,519 | Upgrade
|
| Advertising Expenses | - | 34.78 | 34.89 | 18.83 | 18.37 | 36.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.